Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INCA33890 |
Trade Name | |
Synonyms | INCA-33890|INCA 33890 |
Drug Descriptions |
INCA33890 is a bispecific antibody targeting PDCD1 (PD-1) and TGFBR2, which potentially induces cytokine production and inhibits tumor growth (Cancer Res (2023) 83 (7_Supplement): 2936). |
DrugClasses | PD-L1/PD-1 antibody 121 TGFBR2 Antibody 3 |
CAS Registry Number | NA |
NCIT ID | C201142 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
INCA33890 | INCA33890 | 0 | 1 |